Aclaris Therapeutics Stock Price (NASDAQ:ACRS)

Add to My Stocks
$14.98 $0.07 (0.47%) ACRS stock closing price Sep 18, 2018 (Closing)
Prev Close* : $15.05
Market Cap:
$466.26M
Day Low: $14.72
52 Week Low: $14.12
Open: $15.05
Volume: -
Day High: $15.26
52 Week High: $28.62
Dividend:
0.00

Latest Stock Market News

Latest Articles

Aclaris Therapeutics News - From Partners

ACRS Stockcharts

View ACRS PE ratio, PS ratio stocks charts and compare with peers.
ACRS Chart
Note: Compare Aclaris Therapeutics stock price history with the index and industry peers.

Aclaris Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
71.41
PB ratio (
price to book ratio
)
2.29

Aclaris Therapeutics Returns

ROE
(return on equity)

Aclaris Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
0%

ACRS Industry Peers

Company Price Change (%)
Translate Bio (TBIO)10.350.18 (1.71%)
Electrocore Llc (ECOR)14.410.09 (0.63%)
Novan Inc (NOVN)2.840.03 (1.07%)
Fibrocell Science (FCSC)2.160.06 (2.86%)
Revance (RVNC)24.050.5 (2.12%)
Cipher Pharma (CPHR)2.990 (0%)
Rxi Pharma (RXII)1.180.04 (3.28%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Aclaris Therapeutics Inc Stock News - Partner Headlines

Weekly CEO Buys Highlight   on Apr 16, 2018

Aclaris Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues1.68M----
Net Income-68.52M-48.07M-20.56M-8.51M-5.23M
Total Operating Expense72.89M48.56M20.65M8.52M5.24M
View Aclaris Therapeutics income statement
balance sheet20172016201520142013
Total Assets243.5M176.08M94.07M17.37M14.2M
Total Liabilities18.24M6.59M1.55M1.45M-
Shareholders Equity225.26M169.49M92.52M15.92M13.83M
View Aclaris Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-4.25M-1.07M--
Net Cash from (used by) Operating Activities-54.66M-34.6M-20.36M-7.63M-4.92M
Increase (Decrease) in Prop Plant And Equipment-1.23M-0.23M-0.5M-0.41M-
View Aclaris Therapeutics cash flow statement

Aclaris Therapeutics Stock Message Board

Aclaris Therapeutics stock lost 0.47%, and the last close price as of Sep 18, 2018 is $14.98 for ACRS stock. Aclaris Therapeutics market capitalization is $466.26M and it represents the total market value of ACRS stock. Aclaris Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy ACRS stock than sell it, then Aclaris Therapeutics stock price goes up. Conversely, if more investors wanted to sell ACRS stock than buy it, there would be greater supply than demand, and the stock price would fall. 208,646 shares were traded with a closing stock price of $14.98 as of Sep 18, 2018, as can be seen from Aclaris Therapeutics stock quote. One can view Aclaris Therapeutics stock chart to follow the stock price trend. Aclaris Therapeutics paid 0.00 stock dividends to its shareholders during last quarter. Aclaris Therapeutics stock price history, gives the entire historical data for ACRS stock.